Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ali Amini

Ali Amini

Contact information

Email
ali.amini@ndm.ox.ac.uk

Website
https://www.expmedndm.ox.ac.uk/team/ali-amini?msclkid=e9e17111c61c11eca8fb07b50aec0e7b

ORCID
ORCID ID https://orcid.org/0000-0002-6837-8881

Ali Amini

MA (Cantab) MB BChir MRCP DTM&H DPhil

Clinical Lecturer in Infectious Diseases

Recent publications

Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines

Murray SM. et al, (2025), Science Immunology, 10

MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines

Amini A. et al, (2025), Science Immunology, 10

case of disseminated autochthonous Cladophialophora bantiana infection in a renal transplant recipient in the UK

Mackrill SW. et al, (2025), The Lancet Infectious Diseases, 25, e104 - e112

Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity

Amini A. et al, (2024), Current Opinion in Virology, 67, 101412 - 101412

67 Bridging the gap: Linking early post-vaccine events to reactogenicity and later immune responses after viral-vectored and mRNA-based SARS-CoV-2 vaccines

Amini A. et al, (2023), Clinical Infection in Practice, 20, 100269 - 100269

More publications